Loading...

Avatrombopag, an oral thrombopoietin receptor agonist: results of two double‐blind, dose‐rising, placebo‐controlled Phase 1 studies

Avatrombopag is an oral thrombopoietin receptor agonist that has been recently approved for treating thrombocytopenia in chronic liver disease patients needing invasive procedures. Clinical trials supporting this new treatment were guided by two double‐blind, dose‐rising, placebo‐controlled Phase 1...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Haematol
Main Authors: Kuter, David J., Allen, Lee F.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282597/
https://ncbi.nlm.nih.gov/pubmed/30203841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15574
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!